These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 9355077)

  • 1. Fish oil therapy for IgA nephropathy: efficacy and interstudy variability.
    Dillon JJ
    J Am Soc Nephrol; 1997 Nov; 8(11):1739-44. PubMed ID: 9355077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The long-term outcome of patients with IgA nephropathy treated with fish oil in a controlled trial. Mayo Nephrology Collaborative Group.
    Donadio JV; Grande JP; Bergstralh EJ; Dart RA; Larson TS; Spencer DC
    J Am Soc Nephrol; 1999 Aug; 10(8):1772-7. PubMed ID: 10446945
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fish oil therapy in IgA nephropathy.
    Fung SM; Ferrill MJ; Norton LL
    Ann Pharmacother; 1997 Jan; 31(1):112-5. PubMed ID: 8997477
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of fish oil on oxidative stress, lipid profile and renal function in IgA nephropathy.
    Parinyasiri U; Ong-Ajyooth L; Parichatikanond P; Ong-Ajyooth S; Liammongkolkul S; Kanyog S
    J Med Assoc Thai; 2004 Feb; 87(2):143-9. PubMed ID: 15061297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Angiotensin antagonists and fish oil for treating IgA nephropathy.
    Coppo R; Amore A; Peruzzi L; Mancuso D; Camilla R
    Contrib Nephrol; 2007; 157():27-36. PubMed ID: 17495434
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Short-term effects of fish oil treatment on urinary excretion of high- and low-molecular weight proteins in patients with IgA nephropathy.
    Branten AJ; Klasen IS; Wetzels JF
    Clin Nephrol; 2002 Oct; 58(4):267-74. PubMed ID: 12400841
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An "evidence-based" survey of therapeutic options for IgA nephropathy: assessment and criticism.
    Strippoli GF; Manno C; Schena FP
    Am J Kidney Dis; 2003 Jun; 41(6):1129-39. PubMed ID: 12776264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advances in treatment: immunoglobulin A nephropathy.
    Hogg RJ; Waldo B
    Semin Nephrol; 1996 Nov; 16(6):511-6. PubMed ID: 9125795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Use of fish oil to treat patients with immunoglobulin a nephropathy.
    Donadio JV
    Am J Clin Nutr; 2000 Jan; 71(1 Suppl):373S-5S. PubMed ID: 10618000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Treatment of immunoglobulin A nephropathy.
    Schiele J; Nowack R; Julian BA; van der Woude FJ
    Ann Med Interne (Paris); 1999 Feb; 150(2):127-36. PubMed ID: 10392261
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of fish oil in a patient with post-transplantation IgA nephropathy.
    Butani L; Palmer J
    Nephrol Dial Transplant; 2000 Aug; 15(8):1264-5. PubMed ID: 10910466
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic approach of patients with IgA nephropathy.
    Goumenos DS; Brown CB
    Ren Fail; 2004 Mar; 26(2):171-7. PubMed ID: 15287202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and histopathologic associations with impaired renal function in IgA nephropathy. Mayo Nephrology Collaborative Group.
    Donadio JV; Bergstralh EJ; Offord KP; Holley KE; Spencer DC
    Clin Nephrol; 1994 Feb; 41(2):65-71. PubMed ID: 8004831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lisinopril versus lisinopril and losartan for mild childhood IgA nephropathy: a randomized controlled trial (JSKDC01 study).
    Shima Y; Nakanishi K; Sako M; Saito-Oba M; Hamasaki Y; Hataya H; Honda M; Kamei K; Ishikura K; Ito S; Kaito H; Tanaka R; Nozu K; Nakamura H; Ohashi Y; Iijima K; Yoshikawa N;
    Pediatr Nephrol; 2019 May; 34(5):837-846. PubMed ID: 30284023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IgA nephropathy: to treat or not to treat?
    Scheinman JI; Trachtman H; Lin CY; Langman CB; Chan JC
    Nephron; 1997; 75(3):251-8. PubMed ID: 9069444
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunoglobulin A nephropathy: fish oils and beyond.
    Feehally J
    Curr Opin Nephrol Hypertens; 1996 Sep; 5(5):442-6. PubMed ID: 8937814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of fish oil and alpha-tocopherol in immunoglobulin A nephropathy in the rat.
    Kuemmerle NB; Chan W; Krieg RJ; Norkus EP; Trachtman H; Chan JC
    Pediatr Res; 1998 Jun; 43(6):791-7. PubMed ID: 9621989
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of dual blockade of the renin-angiotensin system on urinary protein and transforming growth factor-beta excretion in 2 groups of patients with IgA and diabetic nephropathy.
    Song JH; Lee SW; Suh JH; Kim ES; Hong SB; Kim KA; Kim MJ
    Clin Nephrol; 2003 Nov; 60(5):318-26. PubMed ID: 14640237
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of fish-oil dietary supplement on the progression of mesangial IgA glomerulonephritis.
    Cheng IK; Chan PC; Chan MK
    Nephrol Dial Transplant; 1990; 5(4):241-6. PubMed ID: 2113220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of glucocorticoids therapy for IgA nephropathy: a meta-analysis of randomized controlled trials.
    Cheng J; Zhang X; Zhang W; He Q; Tao X; Chen J
    Am J Nephrol; 2009; 30(4):315-22. PubMed ID: 19546530
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.